Skip to content

Randomized, parallel-controlled trial evaluating the safety and efficacy of Daddy Turtle Kids High Protection Sunscreen

Randomized, parallel-controlled trial evaluating the safety and efficacy of Daddy Turtle Kids High Protection Sunscreen

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108559
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-01-28
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy population

Interventions

Control Group:Physical Sunscreen
Treatment Group:Apply sunscreen

Sponsors

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 3-15 years of age, regardless of gender; 2. Fitzpatrick skin type II-IV (yellow race); 3. Those who have no abnormal growth and development, and the general condition is good; 4. No history of photosensitive skin disease, past and current skin health; 5. Have not taken drugs that affect photosensitivity (such as corticosteroids and other drugs) and photosensitive foods (such as coriander, celery, etc.) before the trial; 6. Subjects are not currently using any drugs that may affect skin condition or reaction, such as antihistamines, anti-inflammatory drugs, corticosteroid drugs, etc.; 7. Agree to suspend the use of other sunscreen products except experimental sunscreen essence during the study; 8. Subjects and their family members are willing to participate in and cooperate with this clinical trial, and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.With underlying systemic disease(s). 2.Patients with psychiatric disorders. 3.Patients with comorbid cognitive impairment. 4.Poor compliance and inability to cooperate with investigators. 5.Other circumstances deemed unsuitable for participation in this clinical study by the investigator.

Design outcomes

Primary

MeasureTime frame
Visual Skin Color Assessment;Exposed Area Erythema Score (EAES);

Secondary

MeasureTime frame
Melanin Index (MI);Transepidermal Water Loss (TEWL);Erythema Index (EI);Stratum Corneum Hydration (SCH);

Countries

China

Contacts

Public ContactDeng Dan

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

dengdan1234567@126.com+86 21 38088100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026